drugset
drugset / Trial / NCT04775979

Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo

NCT04775979 ↗

Phase 4 Completed 20 enrolled Ain Shams University
NaSingle-groupOpen-labelTreatment

Summary

The aim of the present work is to evaluate the efficacy and safety of diphenylcyclopropenone (DPCP) as a depigmenting therapy in extensive Vitiligo.

Timeline

Start
2021-01-17
Primary completion
2021-07-30
Completion
2021-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphencyprone Small molecule — Topical

Indications

vitiligo